NEULANDLAB Q1 FY27 Guidance vs Delivery (NEULANDLAB Management Mirror)

Total Income Surges 119.2% YoY in Q1 FY27; FY27 and FY28 Growth Reaffirmed at 20% Long-Term Trajectory

In the Dec'25 Qtr concall, management projected an aspirational 20%-plus CAGR over the 2026-2036 decade. In the Mar'26 Qtr, this was slightly refined to an 18% to 20% CAGR long-term potential, with performance expected to be lumpy and non-linear. In the Jun'26 Qtr concall, the company reaffirmed its long-term ambition to grow at about 20%, expecting both FY27 and FY28 to align with this trajectory. FY27 is anticipated to be a year of growth driven by development revenues, paving the way for larger commercial volumes in FY28. For the Jun'26 Qtr (Q1 FY27), management reported total income of Rs 650.1 crores during the concall, while the Quarterly Financial Results reported revenue of Rs 64,158 Lakhs (+119.2% YoY).